Two Sigma Advisers’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $118K | Sell |
30,800
-2,300
| -7% | -$8.81K | ﹤0.01% | 2191 |
|
2025
Q1 | $190K | Sell |
33,100
-92,200
| -74% | -$530K | ﹤0.01% | 2151 |
|
2024
Q4 | $625K | Sell |
125,300
-84,000
| -40% | -$419K | ﹤0.01% | 1687 |
|
2024
Q3 | $1.13M | Sell |
209,300
-73,600
| -26% | -$397K | ﹤0.01% | 1358 |
|
2024
Q2 | $936K | Sell |
282,900
-92,000
| -25% | -$305K | ﹤0.01% | 1583 |
|
2024
Q1 | $1.23M | Buy |
374,900
+23,500
| +7% | +$76.8K | ﹤0.01% | 1473 |
|
2023
Q4 | $1.23M | Sell |
351,400
-69,500
| -17% | -$244K | ﹤0.01% | 1537 |
|
2023
Q3 | $2.81M | Sell |
420,900
-13,100
| -3% | -$87.5K | 0.01% | 1013 |
|
2023
Q2 | $3.64M | Sell |
434,000
-93,900
| -18% | -$788K | 0.01% | 902 |
|
2023
Q1 | $5.24M | Sell |
527,900
-62,200
| -11% | -$618K | 0.01% | 789 |
|
2022
Q4 | $4.11M | Sell |
590,100
-307,500
| -34% | -$2.14M | 0.01% | 862 |
|
2022
Q3 | $4.79M | Buy |
897,600
+10,600
| +1% | +$56.6K | 0.01% | 755 |
|
2022
Q2 | $3.54M | Buy |
887,000
+379,300
| +75% | +$1.51M | 0.01% | 922 |
|
2022
Q1 | $2.26M | Sell |
507,700
-181,500
| -26% | -$807K | 0.01% | 1186 |
|
2021
Q4 | $2.76M | Sell |
689,200
-99,200
| -13% | -$397K | 0.01% | 1033 |
|
2021
Q3 | $6.92M | Sell |
788,400
-227,100
| -22% | -$1.99M | 0.02% | 645 |
|
2021
Q2 | $11.5M | Buy |
1,015,500
+180,100
| +22% | +$2.04M | 0.03% | 510 |
|
2021
Q1 | $9.93M | Buy |
835,400
+162,100
| +24% | +$1.93M | 0.03% | 577 |
|
2020
Q4 | $4.62M | Buy |
673,300
+72,700
| +12% | +$499K | 0.01% | 856 |
|
2020
Q3 | $4.45M | Buy |
600,600
+523,600
| +680% | +$3.88M | 0.01% | 805 |
|
2020
Q2 | $321K | Buy |
77,000
+42,700
| +124% | +$178K | ﹤0.01% | 2098 |
|
2020
Q1 | $85K | Buy |
34,300
+24,200
| +240% | +$60K | ﹤0.01% | 2317 |
|
2019
Q4 | $59K | Buy |
+10,100
| New | +$59K | ﹤0.01% | 2286 |
|